Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bidirectional Cohort Study of Longitudinal Changes in Body Composition, Bone Marrow Fat, and Multiorgan Imaging Phenotypes Based on Whole-Body Magnetic Resonance Imaging and Their Associations With Disease

NCT07924891 is registered in ClinicalTrials.gov with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07924891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Bidirectional Cohort Study of Longitudinal Changes in Body Composition, Bone Marrow Fat, and Multiorgan Imaging Phenotypes Based on Whole-Body Magnetic Resonance Imaging and Their Associations With Disease
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
August 31, 2030
Enrollment
6,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

whole-body mri imaging phenotypes

Arms

As registered; 2 arms.

  • Retrospective Cohort

    Adults aged 18 years or older with eligible whole-body MRI examinations and linked clinical data generated at Union Hospital from January 1, 2015 through August 31, 2026. This cohort uses existing records and images; no study-specific intervention is assigned.

  • Prospective Cohort

    Adults aged 18 years or older who undergo whole-body MRI for clinical indications at Union Hospital from September 1, 2026 through August 31, 2029 and provide written informed consent for use of imaging, clinical, and follow-up data. No study-specific intervention is assigned.

Primary endpoints

Registered primary outcome measures; 3 primary.

  • Annualized change in mean vertebral bone marrow fat fraction From the first eligible MRI to subsequent clinically indicated repeat MRI examinations; intervals vary by participant. Retrospective records: Jan 2015-Aug 2026; prospective observation: through Aug 31, 2030.

    Vertebral bone marrow fat fraction will be measured from water-fat MRI within independently validated marrow regions of interest (ROIs), excluding cortical bone and non-marrow soft tissue. A single value is the arithmetic mean across the prespecified vertebral marrow ROIs, using the same vertebral levels in each paired examination. Annualized change is the later mean minus the earlier mean, divided by the elapsed time in years. The reported unit is percentage points/year. Only quality-controlled paired measurements are included.

  • Annualized change in visceral adipose tissue volume From the first eligible MRI to subsequent clinically indicated repeat MRI examinations; intervals vary by participant. Retrospective records: Jan 2015-Aug 2026; prospective observation: through Aug 31, 2030.

    Whole-body MRI with automated or semiautomated visceral adipose tissue segmentation and manual quality review. For each eligible pair of MRI examinations, annualized change is calculated as the later value minus the earlier value, divided by the elapsed time in years. The reported unit is L/year. Only paired measurements passing phenotype-specific quality control are included.

  • Annualized change in skeletal muscle volume From the first eligible MRI to subsequent clinically indicated repeat MRI examinations; intervals vary by participant. Retrospective records: Jan 2015-Aug 2026; prospective observation: through Aug 31, 2030.

    Whole-body MRI with automated or semiautomated skeletal muscle segmentation and manual quality review. For each eligible pair of MRI examinations, annualized change is calculated as the later value minus the earlier value, divided by the elapsed time in years. The reported unit is L/year. Only paired measurements passing phenotype-specific quality control are included.

Lead sponsor's other trials

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, most recent start first.